Ampio Pharma has a new corp sec

Mark McGregor yesterday began his new role as the chief financial officer and corporate secretary of Ampio Pharmaceuticals, a $49 million Colorado-based drug developer.

McGregor replaces Bruce Miller, who had served as the company’s CFO and corporate secretary since April 2010 and will be working toward the commercialization of a product that Ampio obtained through its acquisition of DMI BioSciences.

A certified public accountant, McGregor boasts extensive experience in several areas, including risk management and SEC reporting, according to a press release. His 30-year career includes a stint as the vice president, corporate treasurer and corporate development at Storage Technology Corporation, a public company with $2 billion in annual worldwide revenues.

0 comments

You must be registered to comment.

Please Sign In or Register.

We use cookies to make our website function properly and deliver our services. By using our website, you agree to our use of cookies, please click here to learn how to manage and delete cookies.